Dr. Jason Bashir Boudjouk, MD

Dr. Boudjouk practices at Kent Hospital in Warwick, Rhode Island, part of Care New England Health System.

Dr. Boudjouk's NPI, 1255376455, was assigned on June 19, 2006. Dr. Boudjouk holds Rhode Island license MD12133.

Dr. Boudjouk's primary practice is Kent Hospital, at 455 Toll Gate Rd, Warwick, RI 02886 in Kent County. The practice phone is (401) 737-7010.

Dr. Boudjouk's primary practice is Kent Hospital in Warwick, Rhode Island, part of Care New England Health System. Dr. Boudjouk is also affiliated with The Miriam Hospital. Dmand AI also links Dr. Boudjouk to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account. Dr. Boudjouk's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boudjouk practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Boudjouk's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Boudjouk is licensed in Rhode Island.

CMS data shows 843 Medicare services from Dr. Boudjouk across 7 procedure codes in 2024, for 141 Medicare patients. Medicare paid $52,959 for them. Every service was in an office.

CMS counts 141 Medicare patients who saw Dr. Boudjouk in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boudjouk's median patient age at 63, with 38% women.

In 2024, Dr. Boudjouk wrote 7,966 Medicare Part D claims for 379 patients. 90% of them were for generic drugs. CMS names the drug for 7,293 of them, across 136 drugs with 11 or more claims each, at $444,196 in total drug cost. In 2023, CMS named 6,215 claims across 126 drugs.

Dr. Boudjouk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boudjouk as offering telehealth. CMS counts 18 procedures of removal of skin lesions by Dr. Boudjouk, more than 64% of the clinicians it reports for that procedure.

CMS Open Payments shows 320 general payments to Dr. Boudjouk from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $598.